NCT03327441 is a NA clinical trial of Almonds in Microbiota, sponsored by University of Manitoba.

Who is sponsoring NCT03327441?

NCT03327441 is sponsored by University of Manitoba.

What drugs are being tested in NCT03327441?

Interventions in NCT03327441: Almonds, Omelette.

What condition does NCT03327441 study?

NCT03327441 studies Microbiota.

Is NCT03327441 still recruiting?

NCT03327441 is currently terminated. Last updated 17 March 2023.

Last reviewed 2023-03-17 · How we verify

NCT03327441

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Benefits of Almond Consumption in Modulation of Intestinal Microbiome and Novel Disease Risk Biomarkers

Terminated NA Last updated 17 March 2023

What this trial tests

NA trial testing Almonds in Microbiota in 38 participants. Terminated before completion.

Timeline

1 February 2018

Primary endpoint
30 April 2019

31 August 2019

Quick facts

Lead sponsor	University of Manitoba
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	prevention
Enrollment	38
Start date	1 February 2018
Primary completion	30 April 2019
Estimated completion	31 August 2019
Sites	1 location across Canada

Drugs / interventions tested

Almonds
Omelette

Conditions studied

Microbiota — all drugs for Microbiota →

Sponsor

University of Manitoba

Who can join

Adults 18 to 75, any sex, with Microbiota. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overall goal is to assess the health benefits of almond consumption on gut microbiome patterns and their association with circulating disease risk biomarkers, as well as the processes that control those pathways. Health benefits will be assessed relative to a omelette control.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Almonds

Trials testing the same drug.

NCT05782218 — Healthy Unique Lipids From Almonds · NA · completed
NCT04958018 — Almond Supplementation and Exercise Recovery · NA · completed
NCT04778371 — The Effects of Almond Consumption on Functional Performance and Activity in Overweight Active Older Adults · NA · active not recruiting
NCT04223323 — Effects of Almond Consumption on the Human Gastrointestinal Microbiota and Metabolic Health · NA · completed
NCT04243395 — Protein Source on Plasma Amino Acid Concentrations In Older Adults · NA · completed

Other recruiting trials for Microbiota

Currently open trials in the same condition.

NCT07479511 — Adaptation of Lung Transplant Recipients at Extreme Altitude · active not recruiting
NCT07212361 — Infant Microbiota Restoration With Maternal Microbes · NA · recruiting
NCT07029360 — Effectiveness of Coenzyme Q10 and Probiotics in Periodontal Therapy During Pregnancy · NA · recruiting
NCT06809660 — Effects of Endocrine Disruptors on the Gut Microbiota and Assessment of Their Impact on Colorectal Cancer Development (P · NA · recruiting
NCT07154173 — Comprehensive Analysis of Gut Microbiota Signatures in Metastatic Colorectal Cancer · recruiting

Other University of Manitoba trials

Trials by the same sponsor.

NCT07528417 — Evaluation of Antibiotic Prophylaxis in Myelodysplastic Syndromes and Acute Myeloid Leukemia (MYELO-CAN:ABX) · Phase 2 · not yet recruiting
NCT07366515 — Feasibility of a Multimodal Virtual Reality Intervention to Reduce Preoperative Anxiety in Cancer Surgery Patients · NA · not yet recruiting
NCT07354386 — Effects of Dried Whole Fruits on Metabolism in Diabetes · NA · enrolling by invitation
NCT07361315 — Development and Online Evaluation of an Online Course for Parasomnias · NA · recruiting
NCT07023744 — CANnabinoids for Drug Resistant Epilepsy (DRE) in Adults and Children · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03327441 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Manitoba
Last refreshed: 17 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03327441.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing